New Insights into the Rational Use of HCV+ Organs Worldwide.

Clicks: 229
ID: 63389
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Hepatitis C (HCV) is a worldwide health problem. Effective therapies for HCV infection, coupled with an increase in deceased donors due to the opioid epidemic has led to broader availability and use of HCV infected donor organs, including HCV nucleic acid test positive (NAT+) donors in HCV negative recipients. In this review we discuss the prevalence of HCV infection, trends in the use of HCV infected donors and outcomes for those who receive HCV seropositive or HCV NAT+ donor organs. We discuss management considerations such as Hepatitis B reactivation, selection of the optimal direct acting antiviral regimen and potential complications. We also present a framework for the rational use of HCV infected donor organs in the future.
Reference Key
morales2019newclinical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Morales, Jose;Sawinski, Deirdre;
Journal clinical transplantation
Year 2019
DOI
10.1111/ctr.13739
URL
Keywords
hepatitis c kidney transplant liver transplant heart transplant lung transplant

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.